Latest News about Robert Barrow
Recent news which mentions Robert Barrow
MindMed's First Patient Dosing Clinical Trial With LSD For Treatment Of Generalized Anxiety Disorder
August 25, 2022
Tickers
MNMD
From Benzinga
MindMed: Financial And Business Results For Q2 2022, Management And Pipeline Changes
August 12, 2022
From Benzinga
Cannabis Movers & Shakers: Mind Medicine, 22nd Century Group, Grown Rogue International
May 24, 2022
From Benzinga
MindMed Appoints Schond L. Greenway As CFO
May 23, 2022
From Benzinga
From Benzinga
MindMed Shares Soar After FDA Approves First Commercial Clinical Trial On LSD In 40 Years
January 26, 2022
Tickers
MNMD
From Benzinga
From Benzinga
MindMed Completes Phase 1 Clinical Trial Of Non-Hallucinogenic Proprietary Derivative Of Ibogaine
January 04, 2022
Tickers
MNMD
From Benzinga
Cannabis Movers & Shakers: MindMed & Trulieve Management Shake-Ups, Credex Corp & CapStone Bolster Leadership Teams
December 29, 2021
From Benzinga
MindMed Shares Update On Phase 2b Trials of LSD For Treating Generalized Anxiety Disorder
December 22, 2021
Tickers
MNMD
From Benzinga
MindMed Advances Phase 2a LSD Microdose Trial For Adult ADHD
December 17, 2021
Tickers
MNMD
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|